Artiva Biotherapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ARTV on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5505 Morehouse Drive, San Diego, CA

Insiders trading volume in the past year

Artiva Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fred Aslan President and CEO, Director $1.16M -$91.1K -7.27% Nov 15, 2025
Jennifer Bush COO, CLO, Secy, Compliance Off $481K Nov 15, 2025
Neha Krishnamohan Chief Financial Officer $323K Nov 15, 2025
Christopher Horan Chief Tech Operations Officer $254K Nov 15, 2025
Subhashis Banerjee Chief Medical Officer $154K Apr 8, 2025
Heather Raymon SVP, Research and Development $129K Nov 15, 2025
Ra Capital Management, L.P. Director, 10%+ Owner Jun 24, 2025
Daniel G. Baker Director Jun 24, 2025
Laura Bessen Director Jul 18, 2024
Yong-Jun Huh Director Jul 22, 2024
Brian Daniels Director Jun 24, 2025
Hougen Elizabeth L Director Jun 24, 2025
Laura Stoppel Director Jun 24, 2025
GC Corp. 10%+ Owner Jul 22, 2024
Thorsten Graef Chief Medical Officer Feb 26, 2025
Alison Moore Director Jun 24, 2025
venBio Global Strategic Fund III, L.P. 10%+ Owner Jul 22, 2024
Gines Diego Miralles Director Jun 24, 2025
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner Jul 22, 2024
5AM Partners VI, LLC 10%+ Owner Jul 22, 2024

Recent Insider Transactions by Companies or Individuals for Artiva Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.